Showing 2,392 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Weight gain & lipodystrophy

Abdominal Body Fat Gains on ART and Viral Load: It Matters Where You Start

Editor's pick
BETA blog
4 March 2015
Starting treatment

Early HIV treatment and isoniazid prophylaxis: why TEMPRANO results do not yet support universal ART at CD4 >500 cells/mm3

Editor's pick
HIV i-Base
3 March 2015
Starting treatment

Inflammation Persists Despite Very Early HIV Treatment

Editor's pick
The Body Pro
27 February 2015
New & experimental HIV treatments

48-week analysis of investigational HIV-1 attachment inhibitor paves way for Phase III trial initiation

Editor's pick
Bristol Myers Squibb press release
26 February 2015
PrEP

Health News Review analysis of Bloomberg's coverage of PrEP

Editor's pick
Health News Review
24 February 2015
Undetectable viral load & treatment as prevention

HIV Positive Guys Need To Consider Going On Meds Earlier — ACON

Editor's pick
Star Observer
23 February 2015
Drug interactions & pharmacokinetics

Isentress (raltegravir) label update

Editor's pick
FDA
19 February 2015
The search for an HIV prevention vaccine

Experimental AIDS Drug Stirs Talk Of Vaccine 'Alternative'

Editor's pick
Huffington Post
19 February 2015
The search for an HIV prevention vaccine

The Search for a Permanent Alternative to HIV Drugs

Editor's pick
Wall Street Journal
16 February 2015
New & experimental hepatitis C treatment

Health News Review analysis of Reuters' coverage of new hepatitis C drugs

Editor's pick
Health News Review
13 February 2015
HIV treatment

Next-Generation HIV and Hep C Treatment Plans Ahead at CROI

Editor's pick
Medscape (free registration required)
13 February 2015
Pharmaceutical industry

Dutrebis, New HIV Drug, Approved by FDA, but Not Commercially Available

Editor's pick
The Body Pro
11 February 2015
Side effects

HIV Organizations Urge Continuation of D:A:D Study

Editor's pick
Treatment Action Group
11 February 2015
HIV treatment

CROI 2015 Preview: New Research on HIV, Hepatitis C and Ebola

Editor's pick
The Body Pro
11 February 2015
Undetectable viral load & treatment as prevention

US: A Call for Improved HIV-Related Scientific Literacy on the Front Lines

Editor's pick
AIDSMeds
10 February 2015
Epidemiology & behaviour

More African Americans still die of HIV than whites and Latinos combined, CDC says

Editor's pick
Washington Post
9 February 2015
Bad science & bogus treatments

Aids denialism in London – It is really 2015?

Editor's pick
Incidence 0
9 February 2015
New & experimental HIV treatments

CytoDyn Concludes Phase 2b Study With 98% Success With 4 Weeks of Monotherapy

Editor's pick
CytoDyn press release
5 February 2015
Neurological & cognitive problems

Researchers identify key mechanisms underlying HIV-associated cognitive disorders

Editor's pick
Medical Xpress
4 February 2015
New & experimental HIV treatments

Treatment of the First HIV Positive Patient in ABIVAX's Phase IIa Clinical Trial With ABX464

Editor's pick
ABIVAX press release
2 February 2015
New & experimental HIV treatments

PREZCOBIX™ (darunavir/cobicistat) approved in the U.S. for the treatment of adults living with HIV-1

Editor's pick
Janssen press release
30 January 2015
New & experimental HIV treatments

U.S. Food and Drug Administration approves Bristol-Myers Squibb’s Evotaz™ (atazanavir and cobicistat) for the treatment of HIV-1 infection in adults

Editor's pick
Bristol-Myers Squibb press release
30 January 2015
Access to healthcare

Russia may face shortage of anti-AIDS drugs in 2015

Editor's pick
EATG
29 January 2015
Bad science & bogus treatments

Déjà Vu – Claims of HIV Cures and Re-Treading Old Ground

Editor's pick
Nigeria Health Watch
28 January 2015